| Survivors | Non-survivors | P |
---|---|---|---|
n = 39 | n = 58 | ||
Age (years) | 57 ± 16 | 66 ± 15 | 0.007 |
Male (%) | 25 (64) | 42 (72) | 0.36 |
Weight (kg) | 79 ± 14 | 76 ± 18 | 0.29 |
APACHE II | 23 ± 5 | 24 ± 7 | 0.31 |
SAPS II | 52 ± 9 | 57 ± 13 | 0.04 |
SOFA day 1 | 12 ± 3 | 12 ± 4 | 0.74 |
SOFA day 3 | 13 ± 4 | 14 ± 3 | 0.27 |
SOFA at start CVVH | 13 ± 4 | 14 ± 3 | 0.27 |
Manifest bleeding (%) | 18 (46) | 24 (41) | 0.65 |
Blood transfusion (%) | 21 (54) | 32 (55) | 0.90 |
Reason of admission (%) | Â | Â | 0.27 |
   Postoperative | 18 (46) | 18 (31) | |
   Respiratory insufficiency | 10 (26) | 25 (43) | |
   Cardiogenic shock | 9 (23) | 10 (17) | |
   After CPR | 1 (3) | 3 (5) | |
   CVVH | 1 (3) | 2 (3) | |
Reason of renal failure (%) | Â | Â | 0.10 |
   Sepsis | 8 (21) | 14 (24) | |
   Ischemic | 19 (49) | 35 (60) | |
   Toxic | 1 (3) | 0 | |
   Metabolic | 2 (5) | 0 | |
   Auto-immune | 2 (5) | 1 (2) | |
   Unknown | 3 (8) | 3 (5) | |
   History of CKD | 4 (10) | 5 (9) | |
At start of CVVH | Â | Â | Â |
Creatinine (μmol/l) | 364 ± 186 | 312 ± 233 | 0.28 |
Urea (mmol/l) | 20.0 ± 7.2 | 21.1 ± 12.0 | 0.63 |
Potassium (mmol/l) | 4.8 ± 0.8 | 4.5 ± 0.8 | 0.10 |
pH | 7.33 ± 0.11 | 7.30 ± 0.10 | 0.12 |
Bicarbonate (mmol/l) | 19.6 ± 3.9 | 18.6 ± 4.2 | 0.24 |
Lactate (mmol/l) | 2.9 ± 2.2 | 4.3 ± 4.0 | 0.09 |
Diuresis (ml/day) | 547 ± 709 | 601 ± 622 | 0.75 |
aPTT (sec) | 50 ± 34 | 55 ± 30 | 0.51 |
PT-INR | 1.63 ± 0.56 | 1.88 ± 0.82 | 0.14 |
Platelets (×109/l) | 116 ± 75 | 107 ± 72 | 0.89 |